Abstract

The aim of study was to develop and validate two simple, sensitive, and extraction-free spectrophotometric methods for the estimation of risperidone in both pure and pharmaceutical preparations. They are based on the charge transfer complexation reactions between risperidone (RSP) as n-electron donor and p-chloranilic acid (p-CA) in method A and 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) in method B as π-acceptors. In method A, RSP reacts with p-CA in methanol to produce a bright pink-colored chromogen measured at 530 nm whereas, in method B, RSP reacts with DDQ in dichloromethane to form orange-colored complex with a maximum absorption at 460 nm. Beer's law was obeyed in the concentration range of 0–25 and 0–50 μg/mL with molar absorptivity of 1.29 × 104 and 0.48 × 104 L/moL/cm for RSP in methods A and B, respectively. The effects of variables such as reagents, time, and stability of the charge transfer complexes were investigated to optimize the procedures. The proposed methods have been successfully applied to the determination of RSP in pharmaceutical formulations. Results indicate that the methods are accurate, precise, and reproducible (relative standard deviation <2 %).

Highlights

  • Risperidone (RSP) chemically known as 4-[2-[4-(6 uorobenzo[d]isoxazole-3-yl)-1-piperidyl]ethyl]-3-methyl2,6-diazabicyclo[4.4.0]deca-1,3-dien-5-one (Figure 1), is the atypical antipsychotic drug with a relatively low incidence of extra pyramidal side effects. It is used for the treatment of schizophrenia, bipolar disorder, and behavior problems in people with autism

  • It is approved for the treatment of irritability in children and adolescents with autism in 2006. e drug is officially included in 2005 European Pharmacopeia, and the official method of its determination is high-performance liquid chromatography [1]

  • Many methods have been employed for the determination of RSP in biological samples including HPLC with electrochemical detection [2, 3] and RP-HPLC with UV detection [4]. e most extensively used technique for its determination is LC-MS/MS, but several procedures using this technique are con ned to biological uids like human plasma [5,6,7,8], plasma and urine [9], and serum [10]

Read more

Summary

Introduction

Risperidone (RSP) chemically known as 4-[2-[4-(6 uorobenzo[d]isoxazole-3-yl)-1-piperidyl]ethyl]-3-methyl2,6-diazabicyclo[4.4.0]deca-1,3-dien-5-one (Figure 1), is the atypical antipsychotic drug with a relatively low incidence of extra pyramidal side effects. It is used for the treatment of schizophrenia, bipolar disorder, and behavior problems in people with autism. In 2003, the FDA-approved RSP for the short-term treatment of the mixed and manic states associated with bipolar disorder. The authors have described the development and validation of two simple and sensitive spectrophotometric methods for the analysis of RSP in pure form and in pharmaceutical samples using p-CA and DDQ as ππ-acceptors.

Experimental Section
General Procedures for Calibration Graph
Results and Discussion
Method B λλmax nm
Method
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call